PT  - JOURNAL ARTICLE
AU  - Duckworth, Christopher
AU  - Chmiel, Francis P.
AU  - Burns, Dan K.
AU  - Zlatev, Zlatko D.
AU  - White, Neil M.
AU  - Daniels, Thomas W. V.
AU  - Kiuber, Michael
AU  - Boniface, Michael J.
TI  - Emergency department admissions during COVID-19: explainable machine learning to characterise data drift and detect emergent health risks
AID  - 10.1101/2021.05.27.21257713
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.27.21257713
4099  - http://medrxiv.org/content/early/2021/06/09/2021.05.27.21257713.short
4100  - http://medrxiv.org/content/early/2021/06/09/2021.05.27.21257713.full
AB  - Supervised machine learning algorithms deployed in acute healthcare settings use data describing historical episodes to predict clinical outcomes. Clinical settings are dynamic environments and the underlying data distributions characterising episodes can change with time (a phenomenon known as data drift), and so can the relationship between episode characteristics and associated clinical outcomes (so-called, concept drift). We demonstrate how explainable machine learning can be used to monitor data drift in a predictive model deployed within a hospital emergency department. We use the COVID-19 pandemic as an exemplar cause of data drift, which has brought a severe change in operational circumstances. We present a machine learning classifier trained using (pre-COVID-19) data, to identify patients at high risk of admission to hospital during an emergency department attendance. We evaluate our model’s performance on attendances occurring pre-pandemic (AUROC 0.856 95%CI [0.852, 0.859]) and during the COVID-19 pandemic (AUROC 0.826 95%CI [0.814, 0.837]). We demonstrate two benefits of explainable machine learning (SHAP) for models deployed in healthcare settings: (1) By tracking the variation in a feature’s SHAP value relative to its global importance, a complimentary measure of data drift is found which highlights the need to retrain a predictive model. (2) By observing the relative changes in feature importance emergent health risks can be identified.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by The Alan Turing Institute. We acknowledge support from the NIHR Wessex ARC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work received ethics approval from the University of Southampton's Faculty of Engineering and Physical Science Research Ethics Committee (ERGO/FEPS/53164). Approval was also obtained from the NHS Health Research authority (20/HRA/1102, IRAS project ID 275577). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from UHS, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of UHS.